Interleukin-1β activation during acute joint inflammation: A limited role for the NLRP3 inflammasome in vivo

Joint Bone Spine

Volumn 78, Issue 2, 2011, Pages 107-110

  Joosten, Leo A B ^a   Ea, Hang Korng ^b,c   Netea, Mihai G ^a   Busso, Nathalie ^d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSERM   (France)

^c CENTRE VIGGO PETERSEN   (France)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Crystal induced inflammation; IL 1; Inflammasome; NLRP3

Indexed keywords

CASPASE; CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA; TRANSCRIPTION FACTOR AP 1;

ARTHRITIS; BONE MARROW; EDITORIAL; GOUT; HUMAN; IN VIVO STUDY; MACROPHAGE ACTIVATION; NEUTROPHIL; NONHUMAN; PROTEIN SYNTHESIS;

ANIMALS; ARTHRITIS; CARRIER PROTEINS; CASPASE 1; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; URIC ACID;

EID: 79952250653     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.11.004     Document Type: Editorial

References (24)

1. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009, 27:519-550.
2. Dinarello C.A. Anti-inflammatory agents: present and future. Cell 2010, 140:935-950.
3. Stehlik C. Multiple interleukin-1beta-converting enzymes contribute to inflammatory arthritis. Arthritis Rheum 2009, 60:3524-3530.
4. Dinarello C.A. IL-1: discoveries, controversies and future directions. Eur J Immunol 2010, 40:599-606.
5. Guma M., Ronacher L., Liu-Bryan R., et al. Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum 2009, 60:3642-3650.
6. Joosten L.A., Netea M.G., Fantuzzi G., et al. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum 2009, 60:3651-3662.
7. Joosten L.A., Netea M.G., Mylona E., et al. Engagement of fatty acids with toll-like receptor 2 drives interleukin-1b production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum 2010, 62:3237-3248.
8. Martinon F., Petrilli V., Mayor A., et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241.
9. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009, 27:229-265.
10. Schroder K., Tschopp J. The inflammasomes. Cell 2010, 140:821-832.
11. Villani A.C., Lemire M., Fortin G., et al. Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat Genet 2009, 41:71-76.
12. Dostert C., Petrilli V., Van Bruggen R., et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008, 320:674-677.
13. Hoffman H.M., Scott P., Mueller J.L., et al. Role of the leucine-rich repeat domain of cryopyrin/NALP3 in monosodium urate crystal-induced inflammation in mice. Arthritis Rheum 2010, 62:2170-2179.
14. Kanneganti T.D., Lamkanfi M., Kim Y.G., et al. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 2007, 26:433-443.
15. Zhou R., Tardivel A., Thorens B., et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010, 11:136-140.
16. Narayan S, Pazar B, Ea HK, et al. Octacalcium phosphate (OCP) crystals induce inflammation in vivo through IL-1 but independent of the NLRP3 inflammasome. Arthritis Rheum. 2010 Nov 15. [Epub ahead of print] PMID: 21080360.
17. Coeshott C., Ohnemus C., Pilyavskaya A., et al. Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci U S A 1999, 96:6261-6266.
18. Ippagunta S.K., Brand D.D., Luo J., et al. Inflammasome-independent role of apoptosis-associated speck-like protein containing a CARD (ASC) in T cell priming is critical for collagen-induced arthritis. J Biol Chem 2010, 285:12454-12462.
19. Kolly L., Karababa M., Joosten L.A., et al. Inflammatory role of ASC in antigen-induced arthritis is independent of caspase-1, NALP-3, and IPAF. J Immunol 2009, 183:4003-4012.
20. Hasegawa M., Imamura R., Kinoshita T., et al. ASC-mediated NF-kappaB activation leading to interleukin-8 production requires caspase-8 and is inhibited by CLARP. J Biol Chem 2005, 280:15122-15130.
21. Hasegawa M., Imamura R., Motani K., et al. Mechanism and repertoire of ASC-mediated gene expression. J Immunol 2009, 182:7655-7662.
22. So A., De Smedt T., Revaz S., et al. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 2007, 9:R28.
23. Terkeltaub R., Sundy J.S., Schumacher H.R., et al. The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study. Ann Rheum Dis 2009, 68:1613-1617.
24. Moltó A., Olivé A. Anti-IL-1 molecules: new comers and new indications. Joint Bone Spine 2010, 77:102-107.